Johnson & Johnson Gets Dismissal of Drug Benefit Plan Claims

Nov. 28, 2025, 4:55 PM UTC

Johnson & Johnson secured dismissal of claims that it mismanaged prescription drug benefits for employees, a New Jersey federal district court said.

Plaintiffs Ann Lewandowski and Robert Gregory failed to show they had standing to allege that J&J breached its fiduciary duty under the Employee Retirement Income Security Act, Judge Zahid N. Quraishi of the US District Court for the District of New Jersey said in a nonprecedential Nov. 26 order granting the company’s motion to dismiss. The plaintiffs have 30 days to file an amended complaint.

Claims that J&J paid excessive fees to pharmacy benefit managers in a way ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.